Cardiovascular diseases, particularly hyperlipidemia, remain a significant global health concern, prompting the need to investigate alternative therapeutic approaches. This research focuses on the pharmacognostic and phytochemical evaluation of an innovative polyherbal formulation developed for its potential antihyperlipidemic properties. The pharmacognostic assessment thoroughly examines the morphological, microscopic, and macroscopic characteristics of the individual plant constituents utilized in the formulation. Additionally, organoleptic properties were utilized to set quality parameters. Subsequent phytochemical analysis aimed to recognize and enumerate bioactive moities present in the formulation. Customary procedures were employed to levy the charisma of alkaloids, flavonoids, phenolic compounds, saponin, terpenoids, and other secondary metabolites recognized for their therapeutic potential. Antioxidant assays were conducted for both individual components and the herbal tablet. The study delves into the synergistic interactions among the constituents to pinpoint and quantify specific chemical compounds responsible for the antihyperlipidemic effects. The outcome of this analysis offer broad indulgence of polyherbal formulation’s pharmacognostic and phytochemical traits, laying the groundwork for its therapeutic potential in managing hyperlipidemia.
No takes yet. Share an insight, caveat, or question.
Agrawal et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: